DB
Dr. Sangeeta Ballav
Sanofi, Dr. Reddy's Institute of Life Sciences, Dr D Y Patil Vidyapeeth University Dr D Y Patil Biotechnology and Bioinformatics Institute
0000-0002-1775-6600
Employment
-
Sanofi Scientific Writer2026 - Present
-
Dr. Reddy's Institute of Life Sciences Scientific researcher2024 - Present
-
Dr D Y Patil Vidyapeeth University Dr D Y Patil Biotechnology and Bioinformatics Institute Scientific researcher2018 - 2024
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (16)
- Scientific Basis for the Therapeutic Uses of Semecarpus anacardium Linn. (Bhallataka): A Systematic Review Save
- Identification of Novel PPAR-β/δ Agonists from Kaempferol, Quercetin, and Resveratrol Derivatives by Targeting Cancer: An Integrative Molecular Docking and Dynamics Simulation Approach Save
- Exploring binding mode assessment of novel kaempferol, resveratrol, and quercetin derivatives with PPAR-α as potent drug candidates against cancer Save
- Design, Synthesis, and Biological Evaluation of Novel Quercetin Derivatives as PPAR‐γ Partial Agonists by Modulating Epithelial–Mesenchymal Transition in Lung Cancer Metastasis Save
- Dietary flavonoids as modulators of non-coding RNAs in hormone-associated cancer Save
- Partial Activation of PPAR‐γ by Synthesized Quercetin Derivatives Modulates TGF‐β1‐Induced EMT in Lung Cancer Cells Save
- Extraction of dermatan sulfate using ionic liquid-assisted enzymatic digestion: An efficient approach Save
- Partial Activation of PPAR-γ by Synthesized Quercetin Derivatives Modulates TGF-β1-Induced EMT in Lung Cancer Cells Save
- PPAR-γ Partial Agonists in Disease-Fate Decision with Special Reference to Cancer Save
- Design, synthesis and biological evaluation of novel quercetin derivatives as PPAR-γ partial agonists by modulating Epithelial-mesenchymal transition in lung cancer metastasis Save